Cellebrite DI (CLBT) Invested Capital (2019 - 2025)
Cellebrite DI (CLBT) has 6 years of Invested Capital data on record, last reported at $484.3 million in Q4 2025.
- For Q4 2025, Invested Capital rose 44.13% year-over-year to $484.3 million; the TTM value through Dec 2025 reached $484.3 million, up 44.13%, while the annual FY2025 figure was $484.3 million, 44.13% up from the prior year.
- Invested Capital reached $484.3 million in Q4 2025 per CLBT's latest filing, up from $336.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $484.3 million in Q4 2025 and bottomed at -$73.3 million in Q4 2021.
- Average Invested Capital over 5 years is $171.0 million, with a median of $73.9 million recorded in 2022.
- Peak YoY movement for Invested Capital: crashed 214.96% in 2021, then surged 882.17% in 2024.
- A 5-year view of Invested Capital shows it stood at -$73.3 million in 2021, then skyrocketed by 200.71% to $73.9 million in 2022, then tumbled by 53.68% to $34.2 million in 2023, then soared by 882.17% to $336.0 million in 2024, then soared by 44.13% to $484.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Invested Capital were $484.3 million in Q4 2025, $336.0 million in Q4 2024, and $34.2 million in Q4 2023.